About-cancer/treatment/drugs/multicentric-castleman-disease

From loveco.care
Revision as of 21:53, 29 October 2019 by FuzzyBot (talk | contribs) (Updating to match new version of source page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Other languages:

Drugs Approved for Multicentric Castleman Disease

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for multicentric Castleman disease. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in multicentric Castleman disease that are not listed here.

Drugs Approved for Multicentric Castleman Disease

Siltuximab

Sylvant (Siltuximab)